FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4328129781> ?p ?o ?g. }

• W4328129781 abstract "Background: Venous thromboembolism (VTE) is a potentially reducible cause of morbidity and mortality in patients undergoing elective hip arthroplasty surgery. The balance of post-operative VTE prophylaxis and risk of post-operative haemorrhage remains at the forefront of surgeon’s mind. The National Institute for Health and Care Excellence (NICE) published updated guidelines in 2018 which recommend the use of both mechanical and pharmacological methods in patients undergoing elective total hip arthroplasty (THA). Objectives: The aim of this study was to present the symptomatic VTE incidence in 8,885 patients who underwent THA between January 1998 and March 2018 with Aspirin as the primary agent for pharmacological thromboprophylaxis. Intermittent calf compression stockings are routinely used from the time of surgery until mobilization (usually the following day) with prophylactic doses of low molecular weight heparin (LMWH) during inpatient stay (from 2005 onwards) and then Aspirin 150mg once daily for six weeks on hospital discharge (or Aspirin only prior to 2005), with use of other therapies occasionally as required. Methods: Analysis of prospective data collection from consecutive patients at a single institution undergoing THA was performed with the incidence of symptomatic deep vein thrombosis (DVT) and pulmonary embolism (PE) occurring within six months of the index operation as the primary outcome measure. Ninety-day all-cause mortality of this cohort of patients was also analysed. Results: 8,885 patients were reviewed. This included 7230 primary, 224 complex primary and 1431 revision cases. The overall incidence of symptomatic VTE after elective THA was 1.11% (99/8885) - with the incidence of symptomatic DVT of 0.59% (52/8885) and the incidence of symptomatic PE of 0.53% (47/8885). There was no significant difference (χ2 test, p=0.239) in the symptomatic VTE incidence between primary (1.20% - 89/7230), complex primary (0.89% - 2/224) and revision cases (0.70% - 10/1431). The 90-day all-cause mortality was 0.88% (78/8885). Cardiovascular and respiratory disease were the main causes of death following surgery. Only 0.03% of deaths (n= 3) within 90 days of index surgery were due to PE. There was no significant difference (p=0.327) in length of stay (and hence amount of pharmacologic prophylaxis with LMWH received by patients before commencement of Aspirin) with the average length of stay for those patients who did not suffer a VTE of 6.8 days compared with 7.6 days for those who did suffer a VTE. Conclusion: Our results support the use of aspirin as an effective form of prophylaxis against symptomatic VTE following THA in contradiction to NICE and American Academy of Orthopaedic Surgery (AAOS) recommendations. It is not associated with an increased incidence in symptomatic DVT, PE or death compared to other published studies. The fact that it is inexpensive, readily available, requires no monitoring and does not pose an increased risk of bleeding are other advantages of using aspirin for VTE prophylaxis." @default.
• W4328129781 created "2023-03-22" @default.
• W4328129781 creator A5005632100 @default.
• W4328129781 creator A5014387758 @default.
• W4328129781 creator A5023102453 @default.
• W4328129781 creator A5028340462 @default.
• W4328129781 creator A5032661199 @default.
• W4328129781 creator A5038210139 @default.
• W4328129781 creator A5058941548 @default.
• W4328129781 creator A5064227247 @default.
• W4328129781 creator A5091290373 @default.
• W4328129781 date "2023-03-21" @default.
• W4328129781 modified "2023-10-01" @default.
• W4328129781 title "Incidence of Symptomatic Venous Thromboembolism (VTE) in 8,885 Elective Total Hip Arthroplasty Patients Receiving Post-operative Aspirin VTE Prophylaxis" @default.
• W4328129781 cites W1625577001 @default.
• W4328129781 cites W1835050253 @default.
• W4328129781 cites W1973068188 @default.
• W4328129781 cites W2005483873 @default.
• W4328129781 cites W2020538743 @default.
• W4328129781 cites W2045264175 @default.
• W4328129781 cites W2068008961 @default.
• W4328129781 cites W2071058513 @default.
• W4328129781 cites W2075215741 @default.
• W4328129781 cites W2123747749 @default.
• W4328129781 cites W2137279768 @default.
• W4328129781 cites W2140657303 @default.
• W4328129781 cites W2254474145 @default.
• W4328129781 cites W2258503797 @default.
• W4328129781 cites W2273805106 @default.
• W4328129781 cites W2302255612 @default.
• W4328129781 cites W2346143363 @default.
• W4328129781 cites W2622832619 @default.
• W4328129781 cites W2804584556 @default.
• W4328129781 cites W2927357727 @default.
• W4328129781 cites W3003777732 @default.
• W4328129781 cites W3008501739 @default.
• W4328129781 cites W3040990997 @default.
• W4328129781 cites W3215462907 @default.
• W4328129781 cites W4220789068 @default.
• W4328129781 cites W4223577669 @default.
• W4328129781 cites W4292840770 @default.
• W4328129781 cites W4312043220 @default.
• W4328129781 cites W4318916713 @default.
• W4328129781 doi "https://doi.org/10.7759/cureus.36464" @default.
• W4328129781 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37090282" @default.
• W4328129781 hasPublicationYear "2023" @default.
• W4328129781 type Work @default.
• W4328129781 citedByCount "0" @default.
• W4328129781 crossrefType "journal-article" @default.
• W4328129781 hasAuthorship W4328129781A5005632100 @default.
• W4328129781 hasAuthorship W4328129781A5014387758 @default.
• W4328129781 hasAuthorship W4328129781A5023102453 @default.
• W4328129781 hasAuthorship W4328129781A5028340462 @default.
• W4328129781 hasAuthorship W4328129781A5032661199 @default.
• W4328129781 hasAuthorship W4328129781A5038210139 @default.
• W4328129781 hasAuthorship W4328129781A5058941548 @default.
• W4328129781 hasAuthorship W4328129781A5064227247 @default.
• W4328129781 hasAuthorship W4328129781A5091290373 @default.
• W4328129781 hasBestOaLocation W43281297811 @default.
• W4328129781 hasConcept C120665830 @default.
• W4328129781 hasConcept C121332964 @default.
• W4328129781 hasConcept C126322002 @default.
• W4328129781 hasConcept C141071460 @default.
• W4328129781 hasConcept C188816634 @default.
• W4328129781 hasConcept C2776265017 @default.
• W4328129781 hasConcept C2776884760 @default.
• W4328129781 hasConcept C2777628954 @default.
• W4328129781 hasConcept C2778336525 @default.
• W4328129781 hasConcept C2778890739 @default.
• W4328129781 hasConcept C2778959117 @default.
• W4328129781 hasConcept C2780011451 @default.
• W4328129781 hasConcept C2780868729 @default.
• W4328129781 hasConcept C61511704 @default.
• W4328129781 hasConcept C71924100 @default.
• W4328129781 hasConceptScore W4328129781C120665830 @default.
• W4328129781 hasConceptScore W4328129781C121332964 @default.
• W4328129781 hasConceptScore W4328129781C126322002 @default.
• W4328129781 hasConceptScore W4328129781C141071460 @default.
• W4328129781 hasConceptScore W4328129781C188816634 @default.
• W4328129781 hasConceptScore W4328129781C2776265017 @default.
• W4328129781 hasConceptScore W4328129781C2776884760 @default.
• W4328129781 hasConceptScore W4328129781C2777628954 @default.
• W4328129781 hasConceptScore W4328129781C2778336525 @default.
• W4328129781 hasConceptScore W4328129781C2778890739 @default.
• W4328129781 hasConceptScore W4328129781C2778959117 @default.
• W4328129781 hasConceptScore W4328129781C2780011451 @default.
• W4328129781 hasConceptScore W4328129781C2780868729 @default.
• W4328129781 hasConceptScore W4328129781C61511704 @default.
• W4328129781 hasConceptScore W4328129781C71924100 @default.
• W4328129781 hasLocation W43281297811 @default.
• W4328129781 hasLocation W43281297812 @default.
• W4328129781 hasLocation W43281297813 @default.
• W4328129781 hasOpenAccess W4328129781 @default.
• W4328129781 hasPrimaryLocation W43281297811 @default.
• W4328129781 hasRelatedWork W1429872456 @default.
• W4328129781 hasRelatedWork W1965476469 @default.
• W4328129781 hasRelatedWork W2037999426 @default.
• W4328129781 hasRelatedWork W2171652010 @default.
• W4328129781 hasRelatedWork W220073818 @default.
• W4328129781 hasRelatedWork W2410487325 @default.

• next